Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders

(MedPage Today) — ORLANDO — Gene therapy exagamglogene autotemcel (exa-cel; Casgevy) — already approved for patients 12 years and older with transfusion-transmissive beta thalassemia (TDT) and sickle cell disease (SCD) — has led to lasting results…